Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

Executive Summary

Following last December’s partnership in CNS with Autifony, BI undertakes a screening collaboration with Domain. Leo maintains its busy deal-making pace, partnering in dermatology with Evotec.

Advertisement

Related Content

Brii Builds China Ops With Hep B Assets, New Partnerships
Mereo Makes It Stateside With OncoMed Merger
UPDATED: Clear 'Yes' From Shareholders On Takeda/Shire Deal
GSK Embraces PARP Promise With Tesaro Buy
CVS CEO Larry Merlo On What Comes Next After Aetna Merger
Impressive Clinical Results For Argenx’s Oncology Candidate Seal The Deal for Janssen
Alligator CEO Discusses Pipeline Additions, Milestone Expectations And The IO Deal Landscape
Deal Watch: Amgen Outsources Celiac Drug To Provention; Lilly, NextCure Will Co-Discover IO Drugs
Almirall Taps Evotec For Novel Dermatology Mechanism
Reducing The Pain Of Skin R&D: Almirall And Leo Collaborate

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC124303

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel